"Das Lindenhofspital ist seit über 100 Jahren traditionell der Pflege verpflichtet. Ihr Aufenthalt bei uns ist von Menschlichkeit, modernster Medizin und hoher Fachkompetenz geprägt. Unsere Ärztinnen, Ärzte, Mitarbeiterinnen und Mitarbeiter der unterschiedlichen Fachbereiche engagieren sich täglich für unseren hohen Qualitätsstandard und für Ihre persönliche Betreuung."

During the past decade, Lindenhofspital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lindenhofspital" #1 sponsor was "Celgene" with 3 trials, followed by "ECRI bv" with 1 trials sponsored, "Medacta International SA" with 1 trials sponsored, "Swiss Group for Clinical Cancer Research" with 1 trials sponsored and "University Hospital Inselspital, Berne" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lindenhofspital" #1 collaborator was "Cardialysis B.V." with 1 trials as a collaborator, "European Cardiovascular Research Center" with 1 trials as a collaborator, "Terumo Medical Corporation" with 1 trials as a collaborator, "University Hospital Freiburg" with 1 trials as a collaborator and "University of Bern" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Lindenhofspital" are "Crohn Disease" (3 trials), "Avascular Necrosis" (1 trials), "Bladder Cancer" (1 trials), "Coronary Artery Disease" (1 trials) and "Emphysema or COPD" (1 trials). Many other conditions were trialed in "Lindenhofspital" in a lesser frequency.

Most popular intervention types in "Lindenhofspital" are "Drug" (6 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ozanimod" (3 trials), "Placebo" (2 trials), "Aspirin" (1 trials), "Atezolizumab" (1 trials) and "Bronchoscopic Thermal Vapor Ablation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lindenhofspital" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Lindenhofspital". undefined are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Lindenhofspital, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lindenhofspital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".